Table: Cyfuse Biomedical -2024 parent results

Cyfuse Biomedical KK

14/02/2025 07:30

Feb 14 (Reuters)- 
          Cyfuse Biomedical K.K. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended        Year to         NEXT   
               Dec 31, 2024    Dec 31, 2023     Dec 31, 2025      YEAR     
                  LATEST         YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS         FORECAST     H1 FORECAST 
  Sales           54 mln          61 mln          302 mln                  
               (-10.9 pct)      (-83.7 pct)     (+455.8 pct)               
  Operating    loss 896 mln    loss 697 mln      loss 1.22                 
  Recurring    loss 869 mln    loss 586 mln      loss 1.14                 
  Net          loss 872 mln    loss 589 mln      loss 1.14                 
  EPS        loss 108.34 yen  loss 75.42 yen  loss 139.64 yen              
  Ann Div          NIL              NIL             NIL                    
  -Q2 Div          NIL              NIL             NIL                    
  -Q4 Div          NIL              NIL             NIL                    
  
  NOTE - Cyfuse Biomedical K.K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T